(Q40962500)

25 September 2017

title

Filgrastim. A reappraisal of pharmacoeconomic considerations in the prophylaxis and treatment of chemotherapy-induced neutropenia (English)

1 reference

25 September 2017

J E Frampton

1

1 reference

25 September 2017

D Faulds

series ordinal

2

1 reference

25 September 2017

publication date

1 January 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

9

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

76-96

1 reference

Surveillance of colony-stimulating factor use in US academic health centers

25 September 2017

cites work

1 reference

12 December 2020

Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol

1 reference

12 December 2020

Dosage standardization for filgrastim

1 reference

12 December 2020

The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care costs associated with cancer chemotherapy

1 reference

12 December 2020

Haematopoietic growth factors and cancer therapy

1 reference

12 December 2020

Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation

1 reference

12 December 2020

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

12 December 2020

Big cost savings from small filgrastim unit doses

1 reference

12 December 2020

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

1 reference

12 December 2020

The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myeloma

1 reference

12 December 2020

Peripheral blood stem cell transplantations: past, present and future

1 reference

12 December 2020

Economic evaluation of peripheral blood stem cell transplantation for lymphoma

1 reference

12 December 2020

Use of decision analysis to evaluate the costs and benefits of filgrastim (G-CSF) therapy.

1 reference

12 December 2020

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

1 reference

12 December 2020

Dose intensity and high dose therapy. Two different concepts

1 reference

12 December 2020

Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia

1 reference

12 December 2020

Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant

1 reference

12 December 2020

Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation

1 reference

12 December 2020

Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy

1 reference

12 December 2020

Pharmacoeconomics of genetically engineered drugs

1 reference

12 December 2020

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

1 reference

12 December 2020

Filgrastim doses should not be standardized for pediatric patients

1 reference

12 December 2020

Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness

1 reference

12 December 2020

Low-Dose Filgrastim Therapy for Chronic Neutropenia

1 reference

12 December 2020

Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy

1 reference

12 December 2020

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy

1 reference

12 December 2020

Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation

1 reference

12 December 2020

Current status of G-CSF in support of chemotherapy and radiotherapy.

1 reference

12 December 2020

Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recovery.

1 reference

12 December 2020

Prophylactic administration of granulocyte colony-stimulating factor (filgrastim) after conventional chemotherapy in children with cancer

1 reference

12 December 2020

Cost-effectiveness of autologous bone marrow transplantation.

1 reference

12 December 2020

Economic evaluation of prophylaxis with recombinant granulopoiesis stimulating factor

1 reference

12 December 2020

Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women

1 reference

12 December 2020

Granulocyte colony stimulating factor significantly influences neutrophil recovery and duration of hospitalisation in bone marrow transplantation

1 reference

12 December 2020

Delayed commencement of granulocyte colony-stimulating factor following autologous bone marrow transplantation accelerates neutrophil recovery and is cost-effective

1 reference

12 December 2020

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

12 December 2020

The costs of treating febrile neutropenia in patients with malignant blood disorders

1 reference

12 December 2020

Filgrastim--human granulocyte-colony stimulating factor

1 reference

12 December 2020

Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia

1 reference

12 December 2020

Efficacy of delayed granulocyte colony-stimulating factor after autologous BMT

1 reference

12 December 2020

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

1 reference

12 December 2020

Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor

1 reference

12 December 2020

Filgrastim fails to improve haemopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue

1 reference

12 December 2020

Pharmacoeconomic issues in the use of granulocyte-macrophage colony-stimulating factor for bone marrow transplantation or chemotherapy-induced neutropenia

1 reference

12 December 2020

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors

1 reference

12 December 2020

Economic and clinical evaluation of therapy of HIV-related non-Hodgkin's lymphoma with chemotherapy and granulocyte colony-stimulating factor (G-CSF)

1 reference

12 December 2020

Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantation

1 reference

12 December 2020

Prospective physician review of orders for colony-stimulating factors

1 reference

12 December 2020

Economic study of neutropenia induced by myelotoxic chemotherapy

1 reference

12 December 2020

10.2165/00019053-199609010-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

25 September 2017

1053368697

0 references

Fatcat ID

release_hbaifqxnrfayvdqs7pra6mmwha

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hbaifqxnrfayvdqs7pra6mmwha

24 November 2022

mapped directly with Wikidata item

1 reference